Summary- Leading the charge for Narasimhan’s blockbuster launch list is cholesterol therapy Leqvio, which awaits an FDA decision on Jan. 1. Others…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Category:
Companies
-
-
CompaniesPfizerTofacitinib
Pfizer’s XELJANZ® (Tofacitinib) Receives Marketing Authorization in the European Union for the Treatment of Active Ankylosing Spondylitis
by adminby adminAbstract: The European Commission has approved Pfizer`s first-of-its-kind oral Janus kinase (JAK) inhibitor XELJANZ® (Tofacitinib) 5 mg twice daily for the treatment…
-
Gsk
GlaxoSmithKline’s Novel Anemia (Daprodustat) has Notched up A First-In-Class Success While AstraZeneca-FibroGen’s Akebia Failed.
by adminby adminSYNOPSIS: GlaxoSmithKline Plc released positive trial results for a potential blockbuster anemia pill the company is hoping will bolster its pharma portfolio…
-
AstraZenecaDapagliflozin
NICE issues Draft Recommendation for AstraZeneca`s Forxiga (Dapagliflozin) to Treat Adults with Chronic Kidney Disease
by adminby adminAbstract: The National Institute for Health and Care Excellence (NICE) has issued an Appraisal Consultation Document (ACD) for AstraZeneca’s Forxiga (Dapagliflozin) within…
-
Bharat Biotech
Australia has added Bharat Biotech’s Covaxin to the approved list of COVID vaccines.
by adminby adminKEYPOINTS: Australia’s medicines and medical devices regulator on Monday formally recognised India’s Covaxin, a vaccine against the coronavirus as the country’s border…
-
CompaniesNovartis
Novartis’s BLA has been accepted by US FDA & EMA for Kymriah (Tisagenlecleucel) to treat patients with relapsed or refractory follicular lymphoma.
by adminby adminNovartis says that the U.S. and European regulators have accepted its marketing applications for CAR-T cell therapy Kymriah (Tisagenlecleucel) as third-line therapy…
-
CompaniesPfizer
BioNTech Deal With Senegal, Rwanda to Make mRNA Vaccine in Mid 2022
by adminby adminSummary- BioNTech in bid to build manufacturing expertise in Africa Project seeks to avoid repeat of COVID-19 vaccine inequality Backed by EU…
-
CompaniesMerck & Co
Merck’s Keytruda Gets EU Approval for Treatment of Triple-Negative Breast Cancer.
by adminby adminThe European Commission has cleared Keytruda (Pembrolizumab) in combination with chemotherapy as a first-line treatment for locally recurrent, unresectable or metastatic TNBC…
-
UPL Ltd
UPL Ltd. Launches New ‘NPP’ Business Unit to Enhance Biosolutions Capacity for Sustainable Agriculture in Europe.
by adminby adminKeypoints UPL is the largest manufacturer and distributor of biosolutions worldwide. On 28 June 2021 UPL Ltd, a world leader in sustainable…
-
ChinaPharma Science & Research
Green Signal for Kintor Pharma, PD-L1/TGF-β dual-targeting antibody (GT90008) for Tumour Clinical Trail from China NMPA
by adminby adminKintor Pharmaceutical Limited (“Kintor Pharma”, HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced that the clinical trial of…